In adults with narcolepsy, WAKIX is a once-daily medication approved to treat
the two most common symptoms: EDS and cataplexy1,2
the two most common symptoms: EDS and cataplexy1,2
Based on a US retrospective cohort study of insured patients…
The number of people under medical care for narcolepsy begins to peak at 18 to 24 years of age3,*
*This study was conducted to estimate the prevalence of narcolepsy in a US insured population of more than 60 million participants between 2013 and 2016.
Review Real WAKIX Patient Cases From Experienced Clinicians
Ben
26-year-old student with narcolepsy type 1
Justine
22-year-old college student with narcolepsy type 2
Owen
23-year-old pharmacy student with narcolepsy type 1
Abby
24-year-old computer programmer with narcolepsy type 1